Litcius/Paper detail

O-GlcNAcylation and Its Role in Cancer-Associated Inflammation

Muzi Ouyang, Changmeng Yu, Xiaolian Deng, Yingyi Zhang, Xudong Zhang, Fangfang Duan

2022Frontiers in Immunology34 citationsDOIOpen Access PDF

Abstract

Cancer cells, as well as surrounding stromal and inflammatory cells, form an inflammatory tumor microenvironment (TME) to promote all stages of carcinogenesis. As an emerging post-translational modification (PTM) of serine and threonine residues of proteins, O-linked-N-Acetylglucosaminylation (O-GlcNAcylation) regulates diverse cancer-relevant processes, such as signal transduction, transcription, cell division, metabolism and cytoskeletal regulation. Recent studies suggest that O-GlcNAcylation regulates the development, maturation and functions of immune cells. However, the role of protein O-GlcNAcylation in cancer-associated inflammation has been less explored. This review summarizes the current understanding of the influence of protein O-GlcNAcylation on cancer-associated inflammation and the mechanisms whereby O-GlcNAc-mediated inflammation regulates tumor progression. This will provide a theoretical basis for further development of anti-cancer therapies.

Topics & Concepts

InflammationCarcinogenesisStromal cellTumor microenvironmentCancerSignal transductionCell biologyCancer cellSerineBiologyImmune systemCancer researchPhosphorylationImmunologyGeneticsGlycosylation and Glycoproteins ResearchGalectins and Cancer BiologyCarbohydrate Chemistry and Synthesis
O-GlcNAcylation and Its Role in Cancer-Associated Inflammation | Litcius